Rimantadine
- Generic Name
- Rimantadine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H21N
- CAS Number
- 13392-28-4
- Unique Ingredient Identifier
- 0T2EF4JQTU
- Background
An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
- Indication
For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults.
- Associated Conditions
- Influenza A Virus Infection
- Associated Therapies
- -
Hepatitis C Rimantadine and Antiviral Combination Therapy
Completed
- Conditions
- Hepatitis C
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- The Leeds Teaching Hospitals NHS Trust
- Target Recruit Count
- 10
- Registration Number
- NCT01413490
- Locations
- 🇬🇧
St James University Hospital, Leeds, West Yorkshire, United Kingdom
A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01172847
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath